Search results
Author(s):
Paulus Kirchhof
Added:
1 year ago
In this video interview from EHRA 2022, Dr Paulus Kirchhof (University Heart Center Hamburg, Hamburg, DE) discusses the outcomes of the EAST-AFNET 4 Study, and the applicability of these findings in clinical practice.
Discussion points:
An outline of the EAST-AFNET 4 Study
Benefits of early AF treatment
Observations from clinical practice
Take-home messages
Further research required
…
View more
Author(s):
Ajay J Kirtane
Added:
6 years ago
In this video Dr Ajay Kirtane discusses the way in which DEFINE-FLAIR has affected his clinical practice.
View more
Author(s):
MT Bajén
,
J Martin-Comin
Added:
3 years ago
During the last few years we have been facing a revolution in the field of cardioimaging for both diagnostic and short- and long-term prognostic purposes. The introduction of multislice computed tomography (CT) in clinical practice has allowed us to carry out non-invasive coronariography or, when performed without contrast agents, the imaging of coronary artery calcification. Arteriosclerosis can…
View more
Author(s):
Christian Müller
Added:
3 years ago
B-type natriuretic peptide (BNP) and N-terminal prohormone brain natriuretic peptide (NT-proBNP) have been shown to be extremely helpful in the diagnosis and management of patients with heart failure (HF). These neurohormones are secreted from both the left and the right cardiac ventricle in response to ventricular volume expansion and pressure overload. BNP and NT-proBNP can be seen as…
View more
Author(s):
Christian Müller
Added:
3 years ago
B-type natriuretic peptide (BNP) and N-terminal prohormone brain natriuretic peptide (NT-proBNP) have been shown to be extremely helpful in the diagnosis and management of patients with heart failure (HF). These neurohormones are secreted from both the left and the right cardiac ventricle in response to ventricular volume expansion and pressure overload. BNP and NT-proBNP can be seen as…
View more
Author(s):
Leif Erhardt
,
Jean-Jacques Mourad
Added:
3 years ago
According to data provided by the National Center for Health Statistics (NCHS), life expectancy in the US increased by six years between 1970 and 2000.1,2 Much of this increase can be attributed to reductions in mortality due to cardiovascular (CV) disease (CVD).2 Similarly, the incidence of CVD-related mortality and morbidity has been falling steadily across the EU since the early 1980s, in…
View more
Author(s):
Gheorghe-Andrei Dan
,
Adrian Catalin Buzea
Added:
3 years ago
Non-antivitamin K oral anticoagulants (NOACs) are no longer ‘new’ drugs: they already are established. Since randomised controlled trials (RCTs) usually enrol highly selected patient populations, the best way to demonstrate new drug efficiency/cost-effectiveness is to use long-term and ‘real-world’ data. In order to understand the NOAC experience in real life properly, one must first understand…
View more
Author(s):
Johannes Mair
Added:
3 years ago
In 1981, de Bold et al.1 provided the definitive demonstration of the endocrine function of the heart by the description of atrial natriuretic peptide (ANP). This was followed by the identification of brain natriuretic peptide, or B-type natriuretic peptide (BNP), in 1988.2,3 This natriuretic peptide (NP) was originally discovered in the porcine brain, but it is synthesised, stored and released…
View more
Author(s):
Carsten W Israel
,
Sebastian Reif
Added:
3 years ago
DrIsrael & DrReif (Munich, GER) summarises the results of the VEST RCT publication (NEJM 2018) and the benefits of the WCD according to the initial intention-to-treat and the as-treated analyses.
View more